Connect with us

Business

Morison gearing to re-shape pharmaceutical industry in SL by 2030

Published

on

Morison’s LKR 4 billion worth state-of-the-art pharmaceutical manufacturing plant in Homagama

Sri Lanka’s pharma industry with 1959-roots still producing only 15% of national requirement

Locally manufactured drugs have only 5% market share in private pharma market

Morison to compete with foreign brands with the commencement of commercial manufacturing

by Sanath Nanayakkare

It may be a long journey ahead, but we are going to accomplish it with the support of our science-driven, passionate, young team employed at our pharmaceutical manufacturing plant in Homagama, Dinesh Athapaththu, MD at Morison PLC told the media recently.

He said so while addressing a media roundtable at the LKR 4 billion worth state-of-the-art pharmaceutical manufacturing plant operating with minimum human involvement and maximum automation.

“We have embarked on a journey upstream of changing the landscape of the pharma manufacturing industry in Sri Lanka in order to make premium healthcare affordable for everyone,” he said.

“Healthcare is in the news for all the wrong reasons. Some Sri Lankan companies like Morison are trying to take the pharmaceutical industry to the next level after decades of stagnation. However, it is not receiving positive media attention, and therefore, the general public of the country as well as many doctors don’t know what Morison is doing to make this crucial investment work for Sri Lanka.

It has been more than three years since we made this investment and most of our resources still go into product development. Sri Lanka commenced pharmaceutical manufacturing in 1959, but it is still manufacturing just 15% of the national requirement whereas our neigbouring countries are far ahead of us in national supply volumes and export volumes.

“India, Pakistan, Bangladesh and Sri Lanka commenced pharma manufacturing in the 1950s which means pharma manufacturing in these countries got off the ground around the same time in history. In Sri Lanka, that feat was achieved by J.L Morison Son & Jones (Ceylon) PLC. Their facility at Aluth Mawatha, Mutwal became one of the pioneers of generic pharmaceutical manufacturing in Sri Lanka. However, 65 years on, Sri Lanka is still producing only 15% of its national medicine requirement whereas India is self-sufficient plus USD 20 billion worth exports, Bangladesh 95% self-sufficient plus exports worth USD 3 billion, Pakistan 70% self-sufficient plus exports worth USD 5 billion.

Morison enhancing the skill-set of young science and pharma graduates in Sri Lanka

“Sri Lanka’s total pharmaceutical market is estimated at about USD 600 million where 40% of that drugs value is dispensed through government hospitals while 60% is dispensed by private pharmacies. Only 25% of the total 15% locally manufactured pharmaceuticals are dispensed by the government. Most local manufacturers focus on supplying this 25% requirement to the government.

On the other hand, in the private market where doctor-prescribed brands are sold, the locally manufactured products have only a 5% market share, meaning 95% of the products sold in the private market are imported drugs. Having studied this, Morison decided to try and change things around even at this late stage by becoming a manufacturer of branded drugs of international standards in addition to being a bulk generic supplier to the government.”

Dinesh Athapaththu Managing Director at Morison

“Before we built the new plant in Homagama, we went to India and Pakistan to see the pharmaceutical plants there. We realized that we have an issue with the absence of high quality plants in Sri Lanka to go out and promote our products among doctors and private pharmacies. It was evident that we needed to bring high quality pharma manufacturing standards into the country in order to be able to manufacture drugs of the highest quality, safety and efficacy standards such as EU GMP. So we made a bold investment of LKR 4 billion to build this plant. We have been running the plant in compliance with WHO GMP (Good Manufacturing Practice) and EU GMP standards.”

‘Morison decided to take a long term view of this industry and enter the private market, without solely depending on government supplies which could be subject to policy changes from time to time. Therefore, our committed mission now is building a credible pharmaceutical brand which can readily compete with reputed imported pharma brands built on a patient-centric approach.”

“Indian pharma is in a good position today after about 60 -65 years’ of dedication. In Sri Lanka, proper pharmaceutical manufacturing has not significantly evolved. So we have to make necessary changes to transform this industry. For that, primarily we need to take a long term view of sustainable growth and subsequently about the return on investment. Our shareholders are being patient and supportive of our strategy.

We need to attract a lot of qualified young people into the industry to come and work because they will grow with the industry as we are gearing to make a notable impact in the pharmaceutical industry in Sri Lanka. be the best pharma brand in Sri Lanka by 2030, and effectively compete with foreign brands. At our Homagama factory, the average age of our workforce is around 30 years. The beauty of that is; in ten years, the most qualified Sri Lankan pharmaceutical manufacturing personnel will be around 40-years old,” a confident Dinesh said.

J.L. Morison Son & Jones (Ceylon) PLC was acquired by Hemas Holdings PLC in 2013, and today it is re-branded as Morison, retaining a sense of that historical legacy.

Morison’s Homagama manufacturing facility at present manufactures five drugs and has developed about 26 drugs out of which 10- 12 are in NMRA for registration and the rest are to be submitted for registration.

Morison is planning to submit for accreditation for their Homagama facility once it fulfills the complex European procedures, after which Morison’s products will have easier access to lucrative foreign markets, thereby earning much needed foreign currency for Sri Lanka.



Business

Trade and investment facilitation upgrade seen as needed for SL

Published

on

South Korean Ambassador Miyon Lee (centre) addresses the forum. On her left is Pathfinder Foundation Chairman Ambassador (Retd) Bernard Goonetilleke.

Sri Lanka should mainly focus on upgrading its trade and investment facilitation system while identifying the paramount importance of the issue, South Korean Ambassador to Sri Lanka Miyon Lee said.

The bureaucratic matters—from Customs clearance to tariff lines, licensing, and registration—should be streamlined, she said at a round table forum recently held at the Colombo Club of the Taj Samudra, Colombo. The forum was organized and conducted by the Pathfinder Foundation Sri Lanka and was presided over by its Chairman, Ambassador (Retd) Bernard Goonetilleke.

Ambassador Lee said that the Sri Lankan government and companies must focus on tourism sector development and also find businesses opportunities with Korea.

She also said that if Sri Lanka wants to attract Korean investment into Sri Lanka, Sri Lanka should highly develop its digital sector.

‘On top of that, If Sri Lankan is to sign a FTA or trade agreements, she should focus on niche markets to supply to Korean companies, she explained.

Ambassador Lee added: ‘Korea is highly digital and AI enabled and Sri Lanka needs to concentrate on that as well.

‘Further, it is going to be very important if you will be able to implement all the obligations that are laid out under a WTO agreement.

‘A single window is part of the overall trade architecture that Sri Lanka has to follow.

‘ I think that also follows with the FTA (Free Trade Agreement) negotiations. From Korea’s experience, when we had the financial crisis in 1997, we only pursued WTO negotiations. FTA negotiations came after the financial crisis.

‘The Asia-Pacific Trade Agreement (APTA) is important in this regard.

‘The APTA arrangement includes China, India, Korea, Nepal and Mongolia and 50 percent of Sri Lankan exports to South Korea benefit from the APTA.

‘But other than that, there is not much trade between the two countries. That’s why I think it is going to be very important for Sri Lanka to pursue the RCEP (Regional Comprehensive Economic Partnership) arrangement.

‘Unfortunately, there is not much appetite for upgrading the APTA because we already have separate FTAs with India and China.

‘ We have huge investments in India and in ASEAN countries. I think it would be very important that Sri Lanka uses that kind of opportunity to see if there is any initiative for Sri Lankan companies to provide supplies to Korean companies working in other countries.’

By Hiran H Senewiratne

Continue Reading

Business

SL in damage-control mode in wake of financial security crisis

Published

on

Deputy Finance Minister Dr. Anil Jayantha Fernando

USD 2.5 million Treasury cyber heist has escalated into a full-blown financial security crisis, with the government scrambling to contain international fallout amid growing fears that multiple foreign debt repayment channels may have been compromised.

In the strongest indication yet of the gravity of the breach, Deputy Finance Minister Dr. Anil Jayantha Fernando told Parliament that investigators had uncovered suspicious irregularities linked to other external payment transactions, including one involving India, suggesting that the cyber intrusion may have extended far beyond the original fraudulent transfer.

The revelation has sent shockwaves through financial and political circles at a time when Sri Lanka is struggling to restore credibility after its historic sovereign default and painful debt restructuring process.

The controversial transfer involved funds earmarked for a debt repayment to Australia Export Finance. However, the money was allegedly diverted into a fraudulent account after what authorities now believe was a sophisticated cyber infiltration targeting Treasury communication and payment authentication systems within the External Resources Department (ERD).

With international confidence hanging in the balance, the Government has moved swiftly to reassure creditors that the incident would not be treated as a sovereign debt default.

Fernando informed Parliament that international debt restructuring advisors had assessed the situation and concluded that the theft constituted a criminal financial breach rather than a deliberate failure by Sri Lanka to honour debt obligations.

Behind the scenes, however, the crisis has triggered an unprecedented multi-agency investigation involving the Criminal Investigation Department (CID), Sri Lanka Computer Emergency Readiness Team (SLCERT), Financial Intelligence Unit (FIU) and foreign law enforcement authorities, including Australian agencies.

Investigators are now carrying out forensic examinations of official email systems, payment authorisation trails, digital devices and Treasury transaction records amid mounting concerns that critical State financial infrastructure may have been exposed to external manipulation.

The scandal has also intensified political tensions, with opposition parties accusing the Government of attempting to downplay the seriousness of the breach while demanding an immediate parliamentary debate and an independent inquiry into Treasury security failures.

Pressure mounted further following the sudden death of an interdicted Finance Ministry official reportedly connected to the ongoing investigation.

Although authorities have not officially linked the death to the fraud probe, the incident has fuelled widespread speculation and heightened public suspicion surrounding the case.

The latest disclosures have raised troubling questions about the vulnerability of Sri Lanka’s public financial systems, particularly as billions of dollars in foreign debt repayments, aid flows and restructuring transactions continue to pass through Government channels under intense international scrutiny.

Financial analysts warn that while creditors may refrain from categorising the incident as a formal default, the cyber heist could still damage Sri Lanka’s credibility unless authorities demonstrate swift accountability, institutional transparency and robust corrective measures.

The Treasury breach is now being viewed not merely as an isolated fraud, but as a major national financial security threat with potentially far-reaching implications for Sri Lanka’s economic recovery and global standing.

By Ifham Nizam

Continue Reading

Business

JKCG Auto partners with BOC and SLIC to support EV adoption

Published

on

John Keells CG Auto (JKCG Auto), the authorised distributor of BYD and DENZA in Sri Lanka, has launched a campaign in partnership with Bank of Ceylon (BOC) and Sri Lanka Insurance Corporation General Ltd. (SLIC) to accelerate New Energy Vehicles (NEV) adoption among government sector employees.

The initiative, which will run from 4 May to 31 July 2026, is designed to improve accessibility and affordability of NEVs for public servants through a structured set of financing, insurance and ownership support mechanisms.

Open to employees across the government sector, the programme reflects a coordinated effort between industry and national institutions to enable a gradual and practical transition towards cleaner transport options.

As part of the collaboration, JKCG Auto will extend a set of ownership support measures across its BYD and DENZA portfolio, including introductory price considerations, access to home charging infrastructure, and aftersales service support. These are complemented by preferential leasing arrangements facilitated by the Bank of Ceylon, alongside tailored insurance solutions and customer support services from Sri Lanka Insurance Corporation.

Continue Reading

Trending